<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04775459</url>
  </required_header>
  <id_info>
    <org_study_id>IRBN232021/CHUSTE</org_study_id>
    <nct_id>NCT04775459</nct_id>
  </id_info>
  <brief_title>Surfactant Replacement Guided by Early Lung Ultrasound Score in Preterm Newborns With Respiratory Distress Syndrome</brief_title>
  <acronym>ECHOSURF</acronym>
  <official_title>Surfactant Replacement Guided by Early Lung Ultrasound Score (LUS) in Preterm Newborns &lt; 33 Weeks With Respiratory Distress Syndrome in the Neonatal Intensive Care Unit of Saint-Etienne.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lung immaturity is a major issue in neonatal unit.The surfactant administration improves the&#xD;
      pulmonary prognosis in premature infants with hyaline membrane disease who escape continuous&#xD;
      positive airway pressure (CPAP).&#xD;
&#xD;
      This surfactant had been administered at 5h25min of life in Saint Etienne from 2016 to 2019.&#xD;
&#xD;
      Studies suggest that the earlier the surfactant is administered, the more it can reduce the&#xD;
      rate of bronchodysplasia and mortality. And some studies show a pulmonary ultrasound could&#xD;
      help to administrate the surfactant earlier This is why a new faster strategy for diagnosing&#xD;
      preterms needing surfactant will be usefulness and have been done in Saint-Etienne since 2021&#xD;
      thanks to a ultrasound score (LUS).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This current study analyzes the impact of early Lungs Ultrasounds which use a&#xD;
      semi-quantitative assessment : the Lung Ultrasound Score (LUS), in preterms &lt;33 weeks on the&#xD;
      time to surfactant administration.&#xD;
&#xD;
      The current hypothesis is that Lung Ultrasound can increase the number of preterms with&#xD;
      surfactant replacement within the first 3 hours of life.&#xD;
&#xD;
      This is a prospective, comparative, observational trial between two different cohorts : the&#xD;
      last 6 months of 2019 (without Score LUS) versus the first 6 months of 2021 (with Score LUS).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2021</start_date>
  <completion_date type="Anticipated">July 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>administration time frame (min of life)</measure>
    <time_frame>day 1</time_frame>
    <description>Time from birth to surfactant administration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>FiO2 maximum</measure>
    <time_frame>Week 1</time_frame>
    <description>Collect in medical record.: the maximal value of FiO2 from birth to one week of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>delay from FiO2 maximum to FiO2 &lt; 21%</measure>
    <time_frame>Week 4</time_frame>
    <description>Collect in medical record</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilation time (day)</measure>
    <time_frame>Week 4</time_frame>
    <description>Collect in medical record : number of day using a ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilation support</measure>
    <time_frame>Week 4</time_frame>
    <description>Collect in medical record : using a invasive ou a non invasive ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bronchodysplasia rate</measure>
    <time_frame>Week 4</time_frame>
    <description>Collect in medical record.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Preterm Birth</condition>
  <arm_group>
    <arm_group_label>Surfactant administration without using score LUS</arm_group_label>
    <description>It is a retrospective cohort : preterm newborns from august 2019 to december 2019 needed a surfactant administration.&#xD;
The surfactant was administrated only if the fraction of inspired oxygen (FiO2) &gt;30% among the Guidelines of 2019</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surfactant administration using score LUS</arm_group_label>
    <description>It is a prospective cohort : preterm newborns from january 2021 to juin 2020 needed a surfactant administration.&#xD;
The surfactant is administrated if FiO2 &gt;30% OR if score LUS &gt;8/18 among the literature</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Surfactant administration until 2020</intervention_name>
    <description>Surfactant is administrated if Fi02 &gt;30% among the Guidelines of 2019</description>
    <arm_group_label>Surfactant administration without using score LUS</arm_group_label>
    <other_name>No LUS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Surfactant administration since 2021</intervention_name>
    <description>Surfactant is administrated if Fi02 &gt;30% OR if score LUS &gt;8/18 among the literature</description>
    <arm_group_label>Surfactant administration using score LUS</arm_group_label>
    <other_name>With LUS</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        preterm newborns &lt; 33 weeks with Respiratory Distress Syndrom needed surfactant&#xD;
        administration&#xD;
&#xD;
        Date of birth from 01/08/19 to 31/12/19 and from 01/01/21 to 30/06/21&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  newborns &lt;33 weeks old&#xD;
&#xD;
          -  born at the Saint Etienne University Hospital&#xD;
&#xD;
          -  respiratory distress syndrome&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  chromosomal abnormality,&#xD;
&#xD;
          -  multi-polymalformations syndrome,&#xD;
&#xD;
          -  congenital pulmonary disease,&#xD;
&#xD;
          -  septic shock,&#xD;
&#xD;
          -  congenital lung infection,&#xD;
&#xD;
          -  meconium inhalation,&#xD;
&#xD;
          -  pneumothorax&#xD;
&#xD;
          -  conditions requiring surgery in the first week of life.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Day</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aurelie CANTAIS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Saint-Etienne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aurelie CANTAIS, MD</last_name>
    <phone>(0)477829295</phone>
    <phone_ext>+33</phone_ext>
    <email>aurelie.cantais@chu-st-etienne.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hugues PATURAL, MD PhD</last_name>
    <email>hughes.patural@chu-st-etienne.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chu de Saint-Etienne</name>
      <address>
        <city>Saint-Ã‰tienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Aurelie CANTAIS, MD</last_name>
      <phone>(0)477829295</phone>
      <phone_ext>+33</phone_ext>
      <email>aurelie.cantais@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Aurelie CANTAIS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hughes PATURAL, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marion TOURNAYRE, resident</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 25, 2021</study_first_submitted>
  <study_first_submitted_qc>February 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2021</study_first_posted>
  <last_update_submitted>February 25, 2021</last_update_submitted>
  <last_update_submitted_qc>February 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Preterm</keyword>
  <keyword>Lung Ultrasound Score</keyword>
  <keyword>Surfactant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Surfactants</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

